Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Approval Round Up: Keytruda, Opdivo Add Claims

Sep 25 2017

• By Michael Cipriano

ApproveOnKeyboard_1200x675

Related Content

BioCryst Flu Treatment’s Success May Hinge On Government Contract

Dec 23 2014

FDA Eyeing Other PD-1/L1 Drugs With Clinical Hold On Keytruda Myeloma Trials

Aug 31 2017

Keeping Track: Oncology Filings Galore In Run-Up To ASCO Meeting

May 28 2017

Merck & Co. Strengthening Its Strong Position In Immuno-Oncology

Jun 13 2017

Keeping Track: A Blizzard Of Submissions And A Small Flurry Of Approvals

Feb 05 2017

Exelixis's CABOSUN Rises For Cabometyx After Bristol's Opdivo/Yervoy Letdown

Aug 17 2017

Related Companies

Merck & Co., Inc.

Bristol Myers Squibb Company

Bristol Myers Squibb Company

Bayer AG

Pfizer Inc.

OptiNose, Inc.

BioCryst Pharmaceuticals, Inc.

Additional Topics

United States Drug Review Approvals Regulation Cancer BioPharmaceutical

More from Product Reviews

More from Pink Sheet

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.